Delivery Order SPE2DX22D0010-SPE2D826FCH73
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of OxyContin tablets 20mg with a ceiling value of $1,815.60. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the parent entity Cencora, Inc., which...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $5,072.23 to AmerisourceBergen Drug Corp on November 9, 2025, for the supply of OxyContin tablets (20mg). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs and...
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $5,072.23 to AmerisourceBergen Drug Corp for OxyContin tablets (20 mg), with completion scheduled for October 27, 2025. This firm fixed-price delivery order, awarded on October 26, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- The Defense Department's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on January 4, 2026, for the supply of OxyContin tablets (20mg) with a ceiling value of $5,072.23 and an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order was issued under a no set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the products will also be performed. The...
- The Defense Logistics Agency's Medical Supply Chain has awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) under a firm fixed-price contract. The award, made on August 31, 2025, with an ultimate completion date of September 2, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support military healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 16, 2025, for OxyContin Tablets 20mg with a ceiling value of $5,072.23. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor for pharmaceutical supply to support military and federal healthcare operations. The ultimate completion date is November 17, 2025, and the place of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin 20mg tablets under a firm fixed-price contract valued at $5,072.23, with an ultimate completion date of December 29, 2025. This non-set-aside award was issued competitively and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999...
- The U.S. Defense Department's Medical Supply Chain awarded a $5,072.23 delivery order to AmerisourceBergen Drug Corp for OxyContin tabs 20mg, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCH73Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $5,072.23 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 11, 2026, for the supply of OxyContin tablets 20mg, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The order will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order supports the federal military healthcare system's pharmaceutical supply requirements through the established prime vendor relationship. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for military treatment facilities and veteran healthcare programs, delivering a comprehensive range of medications and medical supplies across multiple therapeutic domains. The firm fixed-price structure and rapid delivery timeline reflect the expedited nature of this pharmaceutical procurement for ongoing defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/10/26 |